[1]
Ayhan KAMANLI et al. 2021. Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs. Archives of Rheumatology. 36, 1 (Mar. 2021), 001–009. DOI:https://doi.org/10.46497/ArchRheumatol.2021.7874.